<- Go Home
Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Market Cap
GBP 34.7B
Volume
21.8M
Cash and Equivalents
GBP 2.3B
EBITDA
GBP 2.7B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 7.1B
Profit Margin
63.23%
52 Week High
GBP 4.18
52 Week Low
GBP 3.19
Dividend
1.72%
Price / Book Value
2.15
Price / Earnings
24.43
Price / Tangible Book Value
-3.46
Enterprise Value
GBP 42.7B
Enterprise Value / EBITDA
15.60
Operating Income
GBP 2.5B
Return on Equity
8.95%
Return on Assets
4.55
Cash and Short Term Investments
GBP 2.3B
Debt
GBP 10.3B
Equity
GBP 16.2B
Revenue
GBP 11.2B
Unlevered FCF
GBP 2.7B
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium